ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Concalls
Every earnings call, live and summarised
Earnings calls
Every GPT Healthcare earnings call we streamed: the live audio and our summary of what management said.
Q2 revenue rose 14.1% to ₹135.6 Cr and EBITDA 23.9%, driven by occupancy and volume. Raipur break-even slipped from Q3 FY27 to Q1 FY28 amid ~₹9 Cr Q2 losses. Management gave no new quantified targets beyond FY27 growth.
Q2 revenue rose 14.1% to ₹135.6 Cr and EBITDA 23.9%, driven by occupancy and volume. Raipur break-even slipped from Q3 FY27 to Q1 FY28 amid ~₹9 Cr Q2 losses. Management gave no new quantified targets beyond FY27 growth.
FY27 growth guided at 15-16% (metric unspecified); Raipur FY27 loss ~₹10 Cr; Jamshedpur 155 beds, Mar-Apr 2027.
GPT Healthcare shows strong 18.2% revenue growth and 66% PAT growth, but struggles with utilization outside its core Kolkata market.
GPT Healthcare reported Q4 FY26 revenue of ₹128cr (+24% YoY) and EBITDA margin of 19.5%. FY26 revenue stood at ₹478.5cr with an 18.8% margin.
GPT Healthcare delivered strong FY26 results with 24% YoY revenue growth in Q4, driven by the Raipur hospital scale-up and improved utilization in mature facilities like Salt Lake.
GPT Healthcare reported FY26 revenue of ₹478.5 Cr (up 15.1% YoY) and PAT of ₹42.2 Cr. Growth is driven by stronger clinical mix and the new Raipur hospital.
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.